Cargando…
Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors
BACKGROUND: A Stanford University study reported that in asymptomatic GERD patients who were being treated with a proton pump inhibitor (PPI), 50% had pathologic esophageal acid exposure. AIM: We considered the possibility that the high prevalence of pathologic esophageal reflux might simply have re...
Autores principales: | Gerson, Lauren B, Triadafilopoulos, George, Sahbaie, Peyman, Young, Winston, Sloan, Sheldon, Robinson, Malcolm, Miner, Philip B, Gardner, Jerry D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409349/ https://www.ncbi.nlm.nih.gov/pubmed/18498663 http://dx.doi.org/10.1186/1471-230X-8-15 |
Ejemplares similares
-
Exploring the physiologic role of human gastroesophageal reflux by analyzing time‐series data from 24‐h gastric and esophageal pH recordings
por: Lu, Luo, et al.
Publicado: (2014) -
Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020) -
Refractory gastroesophageal reflux disease
por: Subramanian, Charumathi Raghu, et al.
Publicado: (2015) -
Correlation between esophageal pH-metry and esophagitis in gastroesophageal reflux disease in children
por: Lupu, Vasile Valeriu, et al.
Publicado: (2018) -
The relationship between esophageal acidity and symptom frequency in symptomatic nonerosive gastroesophageal reflux disease
por: Gardner, Jerry D.
Publicado: (2022)